Crosswalk

CROSSWALK DOCUMENT FOR CMS 10110 011723.pdf

Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biological and Supporting Regulations (CMS-10110)

Crosswalk

OMB: 0938-0921

Document [pdf]
Download: pdf | pdf
CROSSWALK DOCUMENT FOR CMS 10110
#
1

FORM#
Supporting
Statement A

CHANGE
Supporting document
details were updated to
reflect more accurate
estimates of burden and
the number of respondents.
• The number of
respondents was
increased to 480
from 300.

2

ASP User
Guide

Updated language in
section 1. Introduction and
added a chart to section 3.
ASP Application Home
Page.

RATIONALE
CMS revised the cost burden and
reporting estimates to allow for an
increase in the number of
respondents due to the new
provision that extended ASP
reporting requirements to
manufacturers without Medicaid
Drug Rebate Agreements.
Previously, ASP reporting was
only required for manufacturers of
drugs or biologicals payable under
Part B with a Medicaid rebate
agreement.
CMS updated some outdated
language about the purpose of
ASP and processes of the ASP
application. The chart added to
section 3 depicts the actual
landing page that is shown when
users enter the FFSDCS in the
portal because there are now 3
applications housed within the
FFSDCS, not just ASP.


File Typeapplication/pdf
File TitleCROSSWALK DOCUMENT FOR CMS 10110
SubjectCROSSWALK DOCUMENT FOR CMS 10110
AuthorCMS
File Modified2023-01-18
File Created2023-01-18

© 2024 OMB.report | Privacy Policy